A Rare Case of t(1; 19) Translocation in Acute Myeloid Leukemia: Evaluation of a High-Risk Patients

TL;DR

This paper reports a rare chromosomal translocation in a high-risk AML case, emphasizing its diagnostic and treatment challenges.

Contribution

The novelty lies in presenting a rare t(1; 19) translocation in AML and its clinical implications.

Findings

The t(1; 19) translocation is a rare genetic aberration in AML.

This case highlights the diagnostic and therapeutic challenges of rare translocations in AML.

The case contributes to understanding high-risk AML and clinical decision-making.

Abstract

Acute Myeloid Leukemia (AML) is a heterogeneous malignancy arising from the malignant transformation of hematopoietic stem cells, characterized by the accumulation of blasts in the myeloid lineage. While common cytogenetic alterations in AML play a critical role in prognostic classification, rare chromosomal translocations may have distinct impacts on disease biology and treatment response. In this report, we present a high-risk AML case harboring the t(1; 19) translocation. By highlighting the diagnostic and therapeutic challenges posed by this uncommon genetic aberration, this case aims to contribute to clinical practice in the field of hematology.

Figures